Nektar Therapeutics (NASDAQ: NKTR ) Q2 2014 Earnings Conference Call July 31, 2014 5:00 PM ET Executives ..... Operator Good day, ladies and gentlemen, and welcome to the Nektar Therapeutics Second Quarter 2014 Financial Results Conference Call. At
year for biotechnology investing! Even stocks that scream "sure bet" and "buy now" are getting reamed. Nektar (NASDAQ: NKTR ) is no exception. My biotech portfolio is all paper red and I'm embarrassed. I'm hoping for a big turnaround, but realistically
bowel movements during Week 4 of the Treatment Period. Synergy intends to release top-line data from the trial in Q4. Related tickers: ( NKTR -5.2% ) ( AZN -2.1% ) ( CBST -0.8% ) ( SLXP -1.6% ) ( PGNX ) Post your comment!
company's lead compound, CR845 , in addition to its pipeline of pain therapies. Dr. Medve joins Cara from Nektar Therapeutics ( NKTR +0.7% ) where he was SVP and CMO in charge of clinical development strategy. Post your comment!
technology to develop, manufacture and sell Fovista , Nektar Therapeutics ( NKTR ) receives a $19.75M payment from its partner ..... fee. This was the basis for paying $19.75M to NKTR . NKTR is entitled to as much as $9.5M in additional
By Scrying Biotech : I like biotechnology companies that are underpriced relative to their peers, but also to their prospects. And Regado Biosciences ( RGDO ) is shepherding a disruptive and potentially dominant cardiovascular therapy towards commercialization. Focused on developing acute care ...
(Reuters) - Nektar Therapeutics said its experimental drug to treat chronic pain in patients with arthritis of the knee failed to meet its main goal in a mid-stage clinical trial.
one of the fund's struggling top positions-- Nektar Therapeutics NKTR --slid even further in the downdraft. Several ..... patches. Jennings has held on to top positions in Nektar Therapeutics and Advanced Micro Devices AMD through thick and
surrounding Flamel's early stage pipeline.Flamel may be left empty-handed if competitors such as Alkermes ALKS, Nektar NKTR , and Biovail BVF develop technology superior to the company's Micropump and Medusa systems.Micropump is the only one of
We are dropping coverage of Nektar Therapeutics NKTR to focus our resources elsewhere.